WO2003018793A1 - Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques - Google Patents

Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques Download PDF

Info

Publication number
WO2003018793A1
WO2003018793A1 PCT/JP2002/008408 JP0208408W WO03018793A1 WO 2003018793 A1 WO2003018793 A1 WO 2003018793A1 JP 0208408 W JP0208408 W JP 0208408W WO 03018793 A1 WO03018793 A1 WO 03018793A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
guanine nucleotide
nucleotide exchange
exchange factor
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/008408
Other languages
English (en)
French (fr)
Inventor
Shuichiro Inagaki
Yoshihiro Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP2003523642A priority Critical patent/JP4219808B2/ja
Publication of WO2003018793A1 publication Critical patent/WO2003018793A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP2002/008408 2001-08-23 2002-08-21 Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques Ceased WO2003018793A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003523642A JP4219808B2 (ja) 2001-08-23 2002-08-21 グアニンヌクレオチド交換因子様配列を有する新規遺伝子

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001253344 2001-08-23
JP2001-253344 2001-08-23

Publications (1)

Publication Number Publication Date
WO2003018793A1 true WO2003018793A1 (fr) 2003-03-06

Family

ID=19081693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008408 Ceased WO2003018793A1 (fr) 2001-08-23 2002-08-21 Nouveau gene presentant une sequence de type facteur d'echange de nucleotides guanyliques

Country Status (2)

Country Link
JP (1) JP4219808B2 (ja)
WO (1) WO2003018793A1 (ja)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001029221A2 (en) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Proteins and polynucleotides encoding them
WO2001032676A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 human secreted proteins
WO2001053453A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001029221A2 (en) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Proteins and polynucleotides encoding them
WO2001032676A1 (en) * 1999-10-29 2001-05-10 Human Genome Sciences, Inc. 25 human secreted proteins
WO2001053453A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel bone marrow nucleic acids and polypeptides
WO2001059063A2 (en) * 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ACHSTETTER T. ET AL.: "SEC7 encodes an unusual, high molecular weight protein required for membrane traffic from the yeast golgi apparatus", J. BIOL. CHEM., vol. 263, no. 24, 1988, pages 11711 - 11717, XP002040610 *
AKIRA TOGAWA ET AL.: "Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors", J. BIOL. CHEM., vol. 274, no. 18, 1999, pages 12308 - 12315, XP002966803 *
MORINAGA N. ET AL.: "Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor", PROC. NATL. ACAD. SCI. USA, vol. 94, 1997, pages 12926 - 12931, XP002966802 *

Also Published As

Publication number Publication date
JPWO2003018793A1 (ja) 2004-12-09
JP4219808B2 (ja) 2009-02-04

Similar Documents

Publication Publication Date Title
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
WO2002074979A3 (en) Expression profiles and methods of use
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
WO1999057311A3 (en) Novel method for the identification of clones conferring a desired biological property from an expression library
EP2258722A3 (en) Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
WO2003027306A3 (en) Bgl3 beta-glucosidase and nucleic acids encoding the same
NO962188D0 (no) Nye apoptose-modulerende proteiner, DNA som koder for proteinene og fremgangsmåter for anvendelse derav
EP1365025A4 (en) AGAROSIS AND CORRESPONDING GENE
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
DE60313866D1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
DK1098991T3 (da) Hidtil ukendte fremgangsmåder til identifikation af ligand- og målbiomolekyler
BR0214542A (pt) Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo
WO2003048317A3 (en) Antibodies to magmas and uses thereof
CA2348732A1 (en) Human h37 proteins and cdnas encoding the same
EP1236800A3 (en) Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof
WO2003012120A3 (en) Lp354 mammalian secreted protein
WO2002063009A3 (en) Lp mammalian proteins; related reagents
BR9915537A (pt) Gene prv-1 e sua utilização
AU2003902414A0 (en) Flowering induction
WO2002077009A3 (en) Polypeptides having gamma-glutamyl transpeptidase activity and nucleic acids encoding same
WO2003008448A3 (en) Novel human proton-gated channels
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
WO2000065055A8 (en) Human transporter proteins
WO2002077023A3 (en) A new essential downstream component of the wingless signalling pathway
WO2004058161A3 (en) Hemipteran polo-like kinases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003523642

Country of ref document: JP

122 Ep: pct application non-entry in european phase